ZTS Executive Compensation
* In USD (Original Currency)|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
|---|---|---|---|---|---|---|---|---|
| 2024-04-10 | 2023 | Robert J. Polzer EVP and President of Research and Development | 575,000 | 0 | 948,488 | 538,200 | 62,539 | 2,440,473 |
| 2024-04-10 | 2021 | Heidi C. Chen EVP, General Counsel and Corporate Secretary; Business Lead of Human Health Diagnostics | 615,000 | 0 | 993,543 | 645,750 | 133,861 | 2,719,382 |
| 2024-04-10 | 2022 | Heidi C. Chen EVP, General Counsel and Corporate Secretary; Business Lead of Human Health Diagnostics | 615,000 | 0 | 993,421 | 314,265 | 106,682 | 2,360,602 |
| 2024-04-10 | 2023 | Heidi C. Chen EVP, General Counsel and Corporate Secretary; Business Lead of Human Health Diagnostics | 635,000 | 0 | 1,023,476 | 513,398 | 91,865 | 2,604,988 |
| 2024-04-10 | 2021 | Wafaa Mamilli EVP, Chief Digital and Technology Officer and Group President for China, Brazil and Precision Animal Health | 600,000 | 0 | 712,230 | 727,200 | 195,773 | 2,472,675 |
| 2024-04-10 | 2022 | Wafaa Mamilli EVP, Chief Digital and Technology Officer and Group President for China, Brazil and Precision Animal Health | 608,333 | 0 | 824,915 | 355,267 | 114,561 | 2,178,056 |
| 2024-04-10 | 2023 | Kristin C. Peck Chief Executive Officer | 1,200,000 | 0 | 8,774,860 | 2,106,000 | 232,026 | 15,237,853 |
| 2024-04-10 | 2023 | Wafaa Mamilli EVP, Chief Digital and Technology Officer and Group President for China, Brazil and Precision Animal Health | 650,000 | 0 | 997,334 | 608,400 | 98,267 | 2,686,494 |
| 2024-04-10 | 2021 | Wetteny Joseph Executive Vice President (“EVP”) and Chief Financial Officer | 393,750 | 2,000,000 | 5,099,927 | 472,500 | 43,641 | 8,009,818 |
| 2024-04-10 | 2022 | Wetteny Joseph Executive Vice President (“EVP”) and Chief Financial Officer | 700,000 | 0 | 1,724,722 | 459,900 | 95,448 | 3,555,037 |
| 2024-04-10 | 2023 | Wetteny Joseph Executive Vice President (“EVP”) and Chief Financial Officer | 725,000 | 0 | 1,987,233 | 763,425 | 109,654 | 4,247,772 |
| 2024-04-10 | 2021 | Kristin C. Peck Chief Executive Officer | 1,200,000 | 0 | 6,929,797 | 2,340,000 | 318,724 | 13,098,491 |
| 2024-04-10 | 2022 | Kristin C. Peck Chief Executive Officer | 1,200,000 | 0 | 8,399,841 | 1,314,000 | 289,733 | 14,003,540 |
| 2023-04-06 | 2021 | Glenn C. David EVP and Group President, U.S. Operations, Global Diagnostics and BioDevices | 725,000 | 0 | 2,079,156 | 1,017,900 | 159,250 | 4,674,395 |
| 2023-04-06 | 2022 | Kristin C. Peck Chief Executive Officer | 1,200,000 | 0 | 8,399,841 | 1,314,000 | 289,733 | 14,003,540 |
| 2023-04-06 | 2021 | Kristin C. Peck Chief Executive Officer | 1,200,000 | 0 | 6,929,797 | 2,340,000 | 318,724 | 13,098,491 |
| 2023-04-06 | 2020 | Kristin C. Peck Chief Executive Officer | 1,100,000 | 0 | 5,684,840 | 1,531,200 | 163,297 | 10,374,312 |
| 2023-04-06 | 2022 | Wetteny Joseph Executive Vice President (“EVP”) and Chief Financial Officer | 700,000 | 0 | 1,724,722 | 459,900 | 95,448 | 3,555,037 |
| 2023-04-06 | 2021 | Wetteny Joseph Executive Vice President (“EVP”) and Chief Financial Officer | 393,750 | 2,000,000 | 5,099,927 | 472,500 | 43,641 | 8,009,818 |
| 2023-04-06 | 2022 | Glenn C. David EVP and Group President, U.S. Operations, Global Diagnostics and BioDevices | 725,000 | 0 | 2,079,111 | 0 | 136,359 | 3,633,570 |
| 2023-04-06 | 2020 | Glenn C. David EVP and Group President, U.S. Operations, Global Diagnostics and BioDevices | 725,000 | 0 | 1,912,403 | 672,800 | 130,378 | 4,078,073 |
| 2023-04-06 | 2022 | Heidi C. Chen EVP, General Counsel and Corporate Secretary; Business Lead of Human Health Diagnostics | 615,000 | 0 | 993,421 | 314,265 | 106,682 | 2,360,602 |
| 2023-04-06 | 2021 | Heidi C. Chen EVP, General Counsel and Corporate Secretary; Business Lead of Human Health Diagnostics | 615,000 | 0 | 993,543 | 645,750 | 133,861 | 2,719,382 |
| 2023-04-06 | 2022 | Wafaa Mamilli EVP, Chief Digital and Technology Officer and Group President for China, Brazil and Precision Animal Health | 608,333 | 0 | 824,915 | 355,267 | 114,561 | 2,178,056 |
| 2023-04-06 | 2021 | Wafaa Mamilli EVP, Chief Digital and Technology Officer and Group President for China, Brazil and Precision Animal Health | 600,000 | 0 | 712,230 | 727,200 | 195,773 | 2,472,675 |
| 2023-04-06 | 2020 | Wafaa Mamilli EVP, Chief Digital and Technology Officer and Group President for China, Brazil and Precision Animal Health | 556,489 | 1,250,000 | 974,788 | 559,680 | 237,263 | 4,153,198 |
| 2022-04-06 | 2020 | Roman Trawicki EVP, President of Global Manufacturing and Supply | 675,000 | 0 | 974,792 | 640,980 | 874,470 | 3,490,230 |
| 2022-04-06 | 2021 | Roman Trawicki EVP, President of Global Manufacturing and Supply | 675,000 | 0 | 1,049,922 | 842,400 | 401,419 | 3,318,727 |
| 2022-04-06 | 2019 | Catherine A. Knupp EVP, President of Research and Development | 690,000 | 0 | 1,349,964 | 678,960 | 142,301 | 3,311,222 |
| 2022-04-06 | 2020 | Catherine A. Knupp EVP, President of Research and Development | 710,000 | 0 | 1,349,924 | 658,880 | 137,097 | 3,305,884 |
| 2022-04-06 | 2021 | Catherine A. Knupp EVP, President of Research and Development | 710,000 | 0 | 1,368,661 | 852,000 | 168,376 | 3,555,260 |
| 2022-04-06 | 2019 | Glenn C. David EVP and Group President, International Operations, Aquaculture, BioDevices and Pet Insurance since June 1, 2021; EVP and CFO until May 31, 2021 | 690,000 | 0 | 1,612,477 | 695,520 | 136,866 | 3,672,350 |
| 2022-04-06 | 2020 | Glenn C. David EVP and Group President, International Operations, Aquaculture, BioDevices and Pet Insurance since June 1, 2021; EVP and CFO until May 31, 2021 | 725,000 | 0 | 1,912,403 | 672,800 | 130,378 | 4,078,073 |
| 2022-04-06 | 2021 | Glenn C. David EVP and Group President, International Operations, Aquaculture, BioDevices and Pet Insurance since June 1, 2021; EVP and CFO until May 31, 2021 | 725,000 | 0 | 2,079,156 | 1,017,900 | 159,250 | 4,674,395 |
| 2022-04-06 | 2021 | Wetteny Joseph EVP and CFO since June 1, 2021 | 393,750 | 2,000,000 | 5,099,927 | 472,500 | 43,641 | 8,009,818 |
| 2022-04-06 | 2019 | Kristin C. Peck Chief Executive Officer | 690,000 | 0 | 1,349,964 | 695,520 | 144,683 | 3,330,164 |
| 2022-04-06 | 2021 | Kristin C. Peck Chief Executive Officer | 1,200,000 | 0 | 6,929,797 | 2,340,000 | 318,724 | 13,098,491 |
| 2022-04-06 | 2020 | Kristin C. Peck Chief Executive Officer | 1,100,000 | 0 | 5,684,840 | 1,531,200 | 163,297 | 10,374,312 |
| 2022-04-06 | 2021 | Heidi C. Chen EVP, General Counsel and Corporate Secretary; Lead of Human Health Diagnostics | 615,000 | 0 | 993,543 | 645,750 | 133,861 | 2,719,382 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
